Reaction
Reversible Posterior Leukoencephalopathy Syndrome reporting signals
As of the last recalculation, Reversible Posterior Leukoencephalopathy Syndrome appears in 782 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is VINCRISTINE SULFATE (PRR 39.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vincristine Sulfate | 41 | 39.2 | 39.3 |
| Cyclosporine | 125 | 35.4 | 35.4 |
| Leucovorin Calcium | 21 | 30.0 | 30.1 |
| Anti-Thymocyte Globulin (Rabbit) | 8 | 26.7 | 26.7 |
| Cisplatin | 63 | 23.3 | 23.3 |
| Bevacizumab | 94 | 22.8 | 22.8 |
| Gemcitabine | 30 | 21.0 | 21.1 |
| Mesna Injection | 6 | 19.5 | 19.5 |
| Mesna | 6 | 19.1 | 19.1 |
| Mercaptopurine | 12 | 18.7 | 18.7 |
| Cytarabine | 38 | 17.6 | 17.7 |
| Cyclophosphamide Injection, Solution | 101 | 17.3 | 17.3 |
| Cyclophosphamide | 101 | 17.3 | 17.3 |
| Cyclophosphamide For Injection | 101 | 17.3 | 17.3 |
| Gemcitabine Hydrochloride | 31 | 16.2 | 16.2 |
| Fluorouracil Cream, 0.5% | 41 | 15.0 | 15.1 |
| Fluorouracil | 41 | 14.8 | 14.8 |
| Sunitinib Malate | 20 | 13.9 | 13.9 |
| Sevoflurane | 4 | 12.9 | 12.9 |
| Oxaliplatin | 33 | 12.3 | 12.3 |